These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12731744)

  • 1. Influence of angiotensin converting enzyme inhibitors on stable myocardial ischemia in menopausal cardiac patients.
    Arnaout MS; Khalil A; Alam SE
    Clin Exp Obstet Gynecol; 2003; 30(1):43-6. PubMed ID: 12731744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of captopril on exercise tolerance in patients with chronic stable angina pectoris and normal left ventricular function.
    Steffensen R; Grande P; Madsen JK; Rasmussen S; Haunsø S
    Cardiology; 1995; 86(6):445-50. PubMed ID: 7585753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin-converting enzyme inhibitor alacepril in patients with stable effort angina during chronic isosorbide dinitrate treatment.
    Murohara T; Tayama S; Tabuchi T; Sumida H; Honda T; Hayasaki K; Yasue H
    Am J Cardiol; 1996 Jun; 77(14):1159-63. PubMed ID: 8651088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Does captopril possess antianginal actions? An evaluation of its effects on myocardial ischemia by stress tests in patients with stable angina and normal ventricular function].
    Poveda Sierra JJ; Berrazueta JR; Ochoteco A; Salas E
    Rev Esp Cardiol; 1993 Oct; 46(10):642-7. PubMed ID: 8234999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade.
    van den Heuvel AF; Dunselman PH; Kingma T; Verhorst P; Boomsma F; van Gilst WH; van Veldhuisen DJ
    J Am Coll Cardiol; 2001 Feb; 37(2):470-4. PubMed ID: 11216965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The impact of nitrates and mono-therapy and nitrates combined with angiotensin converting enzyme inhibitors on left ventricular remodeling and exercise capacity in patients after acute myocardial infarction].
    Maciejewicz J; Maziarz A; Celibała R; Wiśniewski M; Wiśniewska M
    Przegl Lek; 2003; 60(2):80-4. PubMed ID: 12939852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine.
    Ikram H; Low CJ; Shirlaw TM; Foy SG; Crozier IG; Richards AM; Khurmi NS; Horsburgh RJ
    Br Heart J; 1994 Jan; 71(1):30-3. PubMed ID: 8297690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
    Borghi C; Ambrosioni E;
    Am Heart J; 2007 Mar; 153(3):445.e7-14. PubMed ID: 17307427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
    Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term anti-ischemic effects of angiotensin-converting enzyme inhibition in patients after myocardial infarction. The Captopril and Thrombolysis Study (CATS) Investigators.
    van den Heuvel AF; van Gilst WH; van Veldhuisen DJ; de Vries RJ; Dunselman PH; Kingma JH
    J Am Coll Cardiol; 1997 Aug; 30(2):400-5. PubMed ID: 9247511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the efficacy of isosorbide dinitrate by captopril in stable angina pectoris.
    Metelitsa VI; Martsevich SYu ; Kozyreva MP; Slastnikova ID
    Am J Cardiol; 1992 Feb; 69(4):291-6. PubMed ID: 1734637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antianginal efficacy of omapatrilat in patients with chronic angina pectoris.
    Chaitman BR; Ivleva AY; Ujda M; Lenis JH; Toth C; Stieber DM; Reisin LH; Pangerl AM; Friedman JB; Lawrence JH
    Am J Cardiol; 2005 Jun; 95(11):1283-9. PubMed ID: 15904630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The angiotensin-converting enzyme inhibitor in the treatment of angina pectoris].
    Bussmann WD; Wittig RA; Brunner I; Bahrmann H
    Dtsch Med Wochenschr; 1992 Apr; 117(16):603-6. PubMed ID: 1568426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of captopril in stable angina pectoris].
    Rodríguez Gilabert C; Antúnez Sánchez J; Miravete Oropeza R
    Arch Inst Cardiol Mex; 1992; 62(3):263-6. PubMed ID: 1632718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exo- and endogenous nitrovasodilators.
    van Gilst WH; de Graeff PA; de Leeuw MJ; Scholtens E; Wesseling H
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):429-36. PubMed ID: 1720843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
    J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term effects of captopril treatment on the course of stable effort angina pectoris and structural-functional characteristics of platelets in patients with hypertension and ischemic heart disease].
    Shafer MZh; Gul'tiaeva EP; Gapon LI; Alfimova TV
    Ter Arkh; 2001; 73(7):64-7. PubMed ID: 11523414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
    Lynch JJ; Stump GL; Wallace AA; Painter CA; Thomas JM; Kusma SE; Gould RJ; Grossman W
    J Am Coll Cardiol; 1999 Sep; 34(3):876-84. PubMed ID: 10483973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors in preventing remodeling and development of heart failure after acute myocardial infarction: results of the German multicenter study of the effects of captopril on cardiopulmonary exercise parameters (ECCE).
    Kleber FX; Sabin GV; Winter UJ; Reindl I; Beil S; Wenzel M; Fischer M; Doering W
    Am J Cardiol; 1997 Aug; 80(3A):162A-167A. PubMed ID: 9293972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.